Tumor Marker

The Alpha-Fetoprotein test is used as a tumor marker to help detect and diagnose cancers of the liver, testicles, and ovaries. Order from Ulta Lab Tests today with results sent confidentially online in 24 to 48 hours after collection.

  • Page
  • 1
  • of
  • 3
  • Total Rows
  • 61
Name Matches
: Blood, Varied, Serum

: Serum

 The CA-1 Cancer Screening - Women panel is specifically designed as an initial screening tool for the early detection of various cancers that commonly affect women. This panel combines several tumor markers and protein measurements, each carefully selected for their relevance in detecting specific cancer types. The panel is an important resource for those who are at increased risk of cancer, either due to family history, genetic predisposition, or other risk factors. By measuring specific biomarkers, this panel helps in identifying cancer at an early stage, where treatment can be more effective and less invasive.
: Serum

: Serum, Blood

 The CA-2 Cancer Screening - Women panel is a specialized diagnostic tool designed for the early detection and ongoing monitoring of various cancers specifically in women. It expands upon basic cancer screening by including additional markers that provide a wider range of detection and insight into different types of cancers. This panel is particularly valuable for women who are at increased risk due to genetic predispositions, family history, or environmental factors. It helps in the early identification of cancer, potentially improving the effectiveness of treatments and increasing the chances of successful outcomes.
: Serum, Blood

: Varied, Blood, Serum

 The CA-3 Cancer Screening - Women panel is an extensive diagnostic tool designed for an in-depth analysis of various cancer-related markers, specifically tailored for women. This advanced screening panel integrates additional markers to enhance the detection and monitoring capabilities for a broad spectrum of cancers. It is instrumental in providing a comprehensive overview of a woman's cancer risk profile, facilitating early intervention, and guiding effective treatment strategies.
: Blood, Varied, Serum

: Blood, Varied, Serum

 The CA-4 Cancer Screening - Women panel is the most comprehensive diagnostic tool available for assessing cancer risk and monitoring the health of women potentially at high risk for various cancers. It encompasses an extensive range of biomarkers, each specifically chosen to detect early signs of cancer and monitor treatment progress or recurrence. This panel is essential for women with a significant family history of cancer, known genetic predispositions, or those who have had previous cancer diagnoses and need close surveillance.
: Varied, Serum, Blood

: Serum

: Varied, Serum

: Serum, Varied

: Serum, Varied

: Serum

: Varied, Serum

: Varied, Serum

: Serum, Varied


 The Cancer Screening - Men panel is a comprehensive diagnostic tool designed to detect early signs of various cancers in men. This panel includes a series of tests that measure specific biomarkers associated with different types of cancer. By assessing these biomarkers, healthcare providers can identify the presence of cancer at an early stage, when treatment is often more effective. This panel is crucial for men who are at higher risk of developing cancer due to factors such as age, family history, or lifestyle.
: Serum

The Cancer Screening - Women Panel is a comprehensive set of blood tests designed to detect various cancer markers in women. This panel assesses levels of specific proteins that can be elevated in the presence of certain types of cancer. By measuring these markers, healthcare providers can gain valuable insights into a patient's risk of having cancer, monitor the progression of the disease, and evaluate the effectiveness of treatment.
: Serum

 The 5-Hydroxyindoleacetic Acid (5-HIAA) 24-hour urine test is a diagnostic test that measures the amount of 5-HIAA in the urine collected over a 24-hour period. 5-HIAA is the primary metabolite of serotonin, a neurotransmitter found primarily in the brain, gastrointestinal tract, and platelets. By assessing the levels of 5-HIAA, health care providers can gain insight into the body's serotonin metabolism.
: Urine

: Varied

: Stool/Feces

The Alpha-1-Antitrypsin Quantitative test is a specialized laboratory assay designed to measure the concentration of alpha-1-antitrypsin (AAT) in the blood. AAT is a protein primarily produced by the liver, and its main function is to inhibit the activity of enzymes that break down lung tissue, protecting the lungs from damage.
: Serum
Also Known As: Alpha1-antitrypsin Test, A1AT Test, AAT Test, Alpha 1 Antitrypsin Serum Test

The Alpha-Fetoprotein (AFP) and AFP-L3 Test measures total AFP and the AFP-L3 fraction in the blood. It helps assess the risk of liver cancer, especially hepatocellular carcinoma, and monitor patients with chronic liver disease. Elevated AFP-L3 levels may indicate a higher likelihood of liver cancer development.

: Serum
Also Known As: AFP Test, Total AFP Test, Alpha-Fetoprotein Tumor Markers, Alpha-Fetoprotein Test

Tumor and Cancer Markers  

Cancer is an ailment in which specific cells grow abnormally or uncontrollably and spread to other cells or parts of the human body. The thing about cancerous cells is that they don't follow the normal process that healthy cells in the body do. Normal cells grow and multiply (through cell division) to form new cells required by the body. When cells become damaged or grow old, they die and get replaced by new ones. However, that's not the case with cancerous cells, as they continue to grow and multiply even when they aren't supposed to. 

When cancerous cells multiply, they form cell masses known as tumors, which grow big enough to interfere with normal body functions and damage healthy tissues. However, it's worth noting that not all types of cancers form tumors (for example, leukemia), and not all tumors found in the body are malignant. Others can be benign, meaning they are non-spreading and non-cancerous.  

... See more